ask="2.44"
ask_size="3000"
average_daily_volume="353432"
bid="2.38"
bid_size="1000"
book_value="4.01"
change="+0.20"
change_from_200_day_moving_average="-3.03"
change_from_50_day_moving_average="-0.89"
change_from_52_week_high="-6.95"
change_From_52_week_low="0.40"
change_in_percent="+8.84%"
close="2.40"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.96"
ebitda="-30.59M"
eps_estimate_current_year="-2.08"
eps_estimate_next_quarter="-0.53"
eps_estimate_next_year="-1.69"
ex_dividend_date="N/A"
float_shares="8427000"
high="2.53"
high_52_weeks="9.35"
last_trade_date="1/4/2017"
last_trade_price="2.40"
last_trade_size="2720"
last_trade_time="4:00pm"
low="2.27"
low_52_weeks="2.00"
market_capitalization="37.30M"
moving_average_200_day="5.43"
moving_average_50_day="3.29"
name="Nivalis Therapeutics
Inc."
notes="N/A"
one_year_target_price="12.08"
open="2.37"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-55.81%"
percent_change_from_50_day_moving_average="-26.98%"
percent_change_from_52_week_high="-74.33%"
percent_change_from_52_week_low="+20.00%"
previous_close="2.20"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.55"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="15543000"
short_ratio="0.40"
stock_exchange="NGM"
symbol="NVLS"
volume="1709445"
weeks_range_52="2.00 - 9.35"
